HomeNewsBusinessSix months on, work from home is still a raging debate for IT sector

Six months on, work from home is still a raging debate for IT sector

The sector employs about 50 lakh employees. But companies are in no hurry to bring them back to office amid the pandemic.

September 27, 2020 / 13:38 IST
Story continues below Advertisement
Representative image
Representative image

After over six months of working from home -- To make WFH permanent or not – is a debate that is raging in the IT sector that employs close to 50 lakh people in the country.

Clearly, the jury is divided.

Story continues below Advertisement

Back in April, India’s largest IT services provider TCS said that the company is making WFH permanent for its employees. The IT major said that by 2025, it is looking at 75 percent of its employees working from home. So it means that only 25 percent of its workforce will have to come to office by 2025.

That took the entire industry by surprise as companies and their clients were getting used to the model.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show